Form 4 for CVKD Cadrenal Therapeutics, Inc.
Accepted 2023-02-13 00:00:00 ET · period of report 2023-02-10 · accession 0001213900-23-010504 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-02-13 | 2023-02-10 | CVKD | Pham Quang X | CEO, COB, Dir, 10% | A - Grant | $1.94 | +25.0K | 3.30M | +0.8% | +$48.5K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-02-10 | A | A | 25,000 | $1.94 | 3,300,000 | D | — | — |